LIVN - LivaNova PLC (LIVN) Q4 2023 Earnings Call Transcript
2024-02-21 10:36:02 ET
LivaNova PLC (LIVN)
Q4 2023 Earnings Conference Call
February 21, 2024 08:00 A.M. ET
Company Participants
Matthew Dodds - SVP, Corporate Development & IT
William Cozy - Chairman and Interim CEO
Alex Shvartsburg - CFO
Stephanie Bolton - President, Global Epilepsy
Conference Call Participants
Rick Wise - Stifel
Anthony Petrone - Mizuho Group
Michael Polark - Wolfe Research
Matt Taylor - Jefferies
Adam Maeder - Piper Sandler
Mike Matson - Needham & Company
David Rescott - Baird
Matt Miksic - Barclays
Presentation
Operator
Good day, ladies and gentlemen and welcome to the LivaNova PLC Fourth Quarter and Full Year 2023 Earnings Conference Call. My name is Emily and I will be moderating your call today. [Operator Instructions]. As a reminder, this conference call is being recorded. I'd now like to introduce your host for today's conference, Mr. Matthew Dodds, LivaNova's Senior Vice President of Corporate Development and IT. Please go ahead sir.
Matthew Dodds
Thank you, Emily and welcome to our conference call and webcast discussing LivaNova's financial results for the fourth quarter and full year of 2023. Joining me on today's call are Bill Cozy, our Chair of the Board of Directors and Interim Chief Executive Officer; Alex Shvartsburg, our Chief Financial Officer; Stephanie Bolton, President of Global Epilepsy; and Briana Gotlin, Director of Investor Relations.
Before we begin, I would like to remind you that the discussions during this call will include forward-looking statements. Factors that could cause actual results to differ materially are discussed in the company's most recent financial filings and documents furnished to the SEC, including today's press release that is available on our website. We do not undertake to update any forward-looking statements. Also, the discussions will include certain non-GAAP financial measures with respect to our performance, including but not limited to sales results, which will all be stated on a constant currency basis. Reconciliations to the most directly comparable GAAP financial measures can be found in today's press release, which is available on our website. We have also posted a presentation to our website that summarizes the points of today's call. This presentation is complementary to other call materials and should be used as an enhanced communication tool. You can find the presentation and press release in the Investors section of our website under News Events and Presentations at investor.LivaNova.com. With that, I will now turn the call over to Bill.
A - William Cozy
Hey, thank you Matt and thank you everyone for joining us. Welcome to LivaNova’s conference call for the fourth quarter and full year of 2023. Before turning to results in the fourth quarter and full year, I'll start off with some comments on the naming of Vlad Makatsaria as CEO, our decision to wind down the Advanced Circulatory Support segment, and an update on the cybersecurity incident. Earlier this month, the Board appointed Vlad is the company's CEO and a member of the Board of Directors effective March 1st. Vlad most recently served as a Company Group Chairman at J&J MedTech, leading its global Ethicon surgery business. He's a respected leader in the medical technology industry, with a 27-year track record of delivering results, driving innovation, and leading high performing teams. The Board and I have great confidence that Vlad is the right CEO to advance LivaNova’s strategic plan and achieve our goals for long-term growth. I will continue in my role as leading over Board Chair, and of course look forward to supporting Vlad as our new CEO. ...
LivaNova PLC (LIVN) Q4 2023 Earnings Call Transcript